Bradley Petrowitz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bradley Petrowitz has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Anna C. Belkina
2 shared publicationsBrian Gould
2 shared publicationsDaniel Villar
2 shared publications- George F. Murphy
Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA
2 shared publications Jidong Shan
2 shared publicationsMarianne James
2 shared publications
Latest Publications
- Open Access
- 8 January 2025
- Published by Wiley in Aging Cell
- Vol. 24 (1)
Additional Cover
Cover legend: The cover image is based on the article A longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring by George Murphy et al., https://doi.org/10.1111/acel.14351.
- 8 January 2025
- Published by Wiley in Aging Cell
- Vol. 24 (1)
Open AccessAdditional Cover
Cover legend: The cover image is based on the article A longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring by George Murphy et al., https://doi.org/10.1111/acel.14351.
- Open Access
- 25 September 2024
- Published by Wiley in Aging Cell
- Vol. 24 (1) , e14351
A longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring
Centenarians provide a unique lens through which to study longevity, healthy aging, and resiliency. Moreover, models of human aging and resilience to disease that allow for the testing of potential interventions are virtually non‐existent. We obtained and characterized over 96 centenarian and offspring peripheral blood samples including those connected to functional independence data highlighting resistance to disability and cognitive impairment. Targeted methylation arrays were used in molecular aging clocks to compare and contrast differences between biological and chronological age in these specialized subjects. Isolated peripheral blood mononuclear cells (PBMCs) from 20 of these subjects were then successfully reprogrammed into high‐quality induced pluripotent stem cell (iPSC) lines which were functionally characterized for pluripotency, genomic stability, and the ability to undergo directed differentiation. The result of this work is a one‐of‐a‐kind resource for studies of human longevity and resilience that can fuel the discovery and validation of novel therapeutics for aging‐related disease.
- 25 September 2024
- Published by Wiley in Aging Cell
- Vol. 24 (1) , e14351
Open AccessA longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring
Centenarians provide a unique lens through which to study longevity, healthy aging, and resiliency. Moreover, models of human aging and resilience to disease that allow for the testing of potential interventions are virtually non‐existent. We obtained and characterized over 96 centenarian and offspring peripheral blood samples including those connected to functional independence data highlighting resistance to disability and cognitive impairment. Targeted methylation arrays were used in molecular aging clocks to compare and contrast differences between biological and chronological age in these specialized subjects. Isolated peripheral blood mononuclear cells (PBMCs) from 20 of these subjects were then successfully reprogrammed into high‐quality induced pluripotent stem cell (iPSC) lines which were functionally characterized for pluripotency, genomic stability, and the ability to undergo directed differentiation. The result of this work is a one‐of‐a‐kind resource for studies of human longevity and resilience that can fuel the discovery and validation of novel therapeutics for aging‐related disease.